- Patients with non-small cell lung cancer harboring ALK receptor tyrosine kinase ( ALK), ROS proto-oncogene 1 ( ROS1), and ret proto-oncogene ( RET) gene rearrangements can benefit from specific kinase inhibitors. Detection of fusion genes is critical for determining the best treatment. Assessing rearrangements in non-small cell lung cancer remains challenging, particularly for lung cytology.

Analysis of Fusion Genes by NanoString System: A Role in Lung Cytology?

Alì, Greta;Giannini, Riccardo;Boldrini, Laura;Fontanini, Gabriella
2018-01-01

Abstract

- Patients with non-small cell lung cancer harboring ALK receptor tyrosine kinase ( ALK), ROS proto-oncogene 1 ( ROS1), and ret proto-oncogene ( RET) gene rearrangements can benefit from specific kinase inhibitors. Detection of fusion genes is critical for determining the best treatment. Assessing rearrangements in non-small cell lung cancer remains challenging, particularly for lung cytology.
2018
Alì, Greta; Bruno, Rossella; Savino, Mauro; Giannini, Riccardo; Pelliccioni, Serena; Menghi, Maura; Boldrini, Laura; Proietti, Agnese; Chella, Antonio...espandi
File in questo prodotto:
File Dimensione Formato  
arpa.2017-0135-ra_Ali et al.pdf

non disponibili

Tipologia: Versione finale editoriale
Licenza: NON PUBBLICO - accesso privato/ristretto
Dimensione 1.86 MB
Formato Adobe PDF
1.86 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/917114
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 36
  • ???jsp.display-item.citation.isi??? 28
social impact